Blood transfusions decrease the incidence of acute rejection in cardiac allograft recipients.

[1]  M C Oz,et al.  Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  D. Roelen,et al.  Regulatory functions of human CD4(+) T cells recognizing allopeptides in the context of self-HLA class II. , 2002, Human immunology.

[3]  G. Persijn,et al.  Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. , 1979, Transplantation.

[4]  Y. Vanrenterghem,et al.  Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. , 1997, Transplantation.

[5]  A. Balk,et al.  Effect of HLA-DR-shared blood transfusion on the clinical outcome of heart transplantation. , 1997, Transplantation.

[6]  M. Suthanthiran,et al.  Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine. , 1991, Transplantation proceedings.

[7]  M. Goldman,et al.  PRETRANSPLANT TRANSFUSIONS IN CARDIAC ALLOGRAFT RECIPIENTS , 1987, Transplantation.

[8]  P M Portner,et al.  Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application. , 1991, The Journal of thoracic and cardiovascular surgery.

[9]  N. Smedira,et al.  Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome? , 1996, The Journal of thoracic and cardiovascular surgery.

[10]  M. Oz,et al.  Impact of Current Management Practices on Early and Late Death in More Than 500 Consecutive Cardiac Transplant Recipients , 2000, Annals of surgery.

[11]  T. Mohanakumar,et al.  Regulatory function of human CD4+ cytolytic T lymphocytes. , 1999, Transplant immunology.

[12]  M. Kocova,et al.  MICROCHIMERISM LINKED TO CYTOTOXIC T LYMPHOCYTE FUNCTIONAL UNRESPONSIVENESS (CLONAL ANERGY) IN A TOLERANT RENAL TRANSPLANT RECIPIENT , 1995, Transplantation.

[13]  R. John,et al.  Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications. , 2003, The Annals of thoracic surgery.

[14]  M. Oz,et al.  Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. , 1998, Circulation.

[15]  M. Oz,et al.  Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? , 1997, Circulation.

[16]  P. Terasaki.  The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. , 1984, Transplantation.

[17]  F. Claas,et al.  Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. , 1989, The New England journal of medicine.

[18]  M. R. Mickey,et al.  Effect of blood transfusions on subsequent kidney transplants. , 1973, Transplantation proceedings.

[19]  J. Kobashigawa,et al.  Pretransplant panel reactive-antibody screens. Are they truly a marker for poor outcome after cardiac transplantation? , 1996, Circulation.

[20]  T. Mohanakumar,et al.  Donor-specific transfusions have long-term beneficial effects for human renal allografts. , 1995, Transplantation.

[21]  S. Dowdy,et al.  Enhanced kidney graft survival in rats by single or multiple blood transfusion(s) and various blood products. , 1982, Transplantation proceedings.

[22]  H. Meryman,et al.  Blood Transfusion and Immunomodulation: A Possible Mechanism , 1993, Vox sanguinis.

[23]  F. Claas,et al.  The influence of allogeneic cells on the human T and B cell repertoire. , 1990, Science.

[24]  K. Orita,et al.  Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization. , 1989, Transplantation proceedings.

[25]  G. Persijn,et al.  Effect of blood transfusions and HLA matching on renal transplantation in the Netherlands. , 1977, Transplantation proceedings.

[26]  D. Singal,et al.  BLOOD TRANSFUSION AND RENAL TRANSPLANTATION , 1985, British journal of haematology.

[27]  J. Cicciarelli.  UNOS Registry data: effect of transfusions. , 1990, Clinical transplants.

[28]  A. Bijnen,et al.  Prolongation of renal allograft survival in DLA tissue-typed beagles after third-party blood transfusions and immunosuppressive treatment. , 1978, Transplantation.

[29]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[30]  R. Cody,et al.  Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[31]  P. Terasaki,et al.  Improvement of kidney-graft survival with increased numbers of blood transfusions. , 1978, The New England journal of medicine.

[32]  G. Abouna,et al.  Effect of pretreatment with multiple blood transfusions and with skin grafts on the survival of renal allografts in mongrel dogs. , 1977, Transplantation proceedings.

[33]  W. Weimar,et al.  Immunologic monitoring of the beneficial effect of one HLA-DR-shared blood transfusion in heart transplant patients. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  M. Fishbein,et al.  Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[35]  W. Whitehouse,et al.  Vaginal thrush treated with bis-2-hydroxy-5-chlorophenyl sulphide. , 1962, Lancet.

[36]  N G Smedira,et al.  Factors influencing HLA sensitization in implantable LVAD recipients. , 1997, The Annals of thoracic surgery.

[37]  R. Marquet,et al.  BLOOD-TRANSFUSIONS INDUCE PROLONGED KIDNEY ALLOGRAFT SURVIVAL IN RHESUS MONKEYS , 1977, The Lancet.

[38]  H. Maeda.  Blood Transfusion and Immunomodulation. , 1997 .

[39]  A. van Es,et al.  Effect of pretransplant transfusions on kidney allograft survival. , 1979, Transplantation proceedings.

[40]  D. Renlund,et al.  Avoidance of cellular blood product transfusions in LVAD recipients does not prevent HLA allosensitization. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[41]  F. Puppo,et al.  Fas, Fas ligand,and transfusion immunomodulation , 2001, Transfusion.

[42]  C. Russo,et al.  Left Ventricular Assist Devices as Bridge to Heart Transplantation: The Niguarda Experience , 2003, Journal of cardiac surgery.

[43]  S. Dzik,et al.  Apoptosis, transforming growth factor‐β, and the immunosuppressive effect of transfusion , 2002, Transfusion.

[44]  T. Myers,et al.  Improved survival after extended bridge to cardiac transplantation. , 1994, The Annals of thoracic surgery.

[45]  T. Mohanakumar,et al.  SELECTIVE LOSS OF FUNCTIONAL ANTIDONOR CYTOLYTIC T CELL PRECURSORS FOLLOWING DONOR‐SPECIFIC BLOOD TRANSFUSIONS IN LONG‐ TERM RENAL ALLOGRAFT RECIPIENTS , 1992, Transplantation.